| Date | Title | Description |
| 14.05.2021 | Publication in the Lancet from the UK Collaborative Trial for Ovarian Cancer Screening | Publication in the Lancet from the UK Collaborative Trial for Ovarian Cancer Screening
Abcodia, a clinical stage company engaged in the commercial development of novel tests for the early detection of cancer, acknowledges the results from U... |
| 15.04.2020 | Abcodia secures £5.35m to launch ovarian cancer test | Specialist biotechnology company Abcodia, winner of Innovative Business of the Year at the 2012 Startups Awards, has raised £5.25m to bring its ovarian cancer screening test ROCA® to market.
The funding round was led by Scottish Equity Part... |
| 07.11.2016 | Scottish Equity Partners just raised one of Europe’s biggest funds this year | Scottish Equity Partners (SEP), a 25-year-old, growth-stage venture capital firm, has closed on £260 million ($322 million) in commitments for its fifth fund, in one of the largest capital raises for a European venture firm this year.
The f... |
| 03.12.2015 | Abcodia announces initial US availability of ovarian cancer test | Abcodia announces initial US availability of ovarian cancer test
03-12-2015
Abcodia Ltd, a clinical stage company engaged in the commercial development of novel tests for the early detection of cancer, has announced the availability of the ... |
| 16.07.2015 | Abcodia scoops One Nucleus BioNewsRound Award | Abcodia scoops One Nucleus BioNewsRound Award
16-07-2015
Abcodia has scooped the One Nucleus BioNewsRound Award for its "creative, significant and exciting" press releases about the ROCA® Test and Abcodia's recent fund raising suc... |
| 18.05.2015 | Abcodia secures £5.25M for ovarian cancer test | Abcodia secures £5.25M for ovarian cancer test |
| 18.05.2015 | Abcodia Raises £5.25m in Funding | Abcodia, a London, UK-based developer of a sensitive and specific ovarian cancer screening test, raised £5.25m in funding.
The round was co-led by Cambridge Innovation Capital (CIC) and Scottish Equity Partners (SEP), with participation fro... |
| 18.05.2015 | Abcodia secures £5.25M for ovarian cancer test | Abcodia secures £5.25M for ovarian cancer test
18-05-2015
Abcodia today announced that it has raised £5.25million funding from existing and new investors to bring the world's most sensitive and specific ovarian cancer screening test, ROCA® ... |
| 12.05.2015 | High performance of Abcodia's ROCA in major ovarian cancer screen trial paves way for launch | High performance of Abcodia's ROCA in major ovarian cancer screen trial paves way for launch
12-05-2015
Abcodia, a specialist company engaged in the development of tests for the early detection of cancer, is to make ROCA® available as an in... |
| 10.12.2014 | Three new biomarker companies selected to work with Abcodia and the Early Cancer Consortium | Three new biomarker companies selected to work with Abcodia and the Early Cancer Consortium
10-12-2014
Three new biomarker companies have been selected to work with the Early Diagnosis Consortium, a collaboration between Cancer Research UK,... |
| 29.10.2014 | Abcodia's Dr Julie Barnes ranked among the UK's top 50 inspirational women in biobusiness | Abcodia's Dr Julie Barnes ranked among the UK's top 50 inspirational women in biobusiness
29-10-2014
Abcodia's CEO Dr Julie Barnes is ranked among the UK's top inspirational women listed in the 50 Movers and Shakers in the BioBusiness 2014.... |
| 18.09.2014 | Abcodia receives Horizon 2020 grant to advance its pancreatic cancer early diagnosis test | Abcodia today announced that it has secured a grant from the European Commission’s Horizon 2020 programme to validate an algorithm-based test for the screening of individuals at high risk of pancreatic cancer. The test will be one of the fi... |
| 18.09.2014 | Abcodia receives Horizon 2020 grant to advance its pancreatic cancer early diagnosis test | Abcodia receives Horizon 2020 grant to advance its pancreatic cancer early diagnosis test
18-09-2014
Abcodia today announced that it has secured a grant from the European Commission’s Horizon 2020 programme to validate an algorithm-based te... |
| 17.09.2014 | Abcodia to collaborate with OncoCyte Corporation on breast cancer diagnostic development | Abcodia to collaborate with OncoCyte Corporation on breast cancer diagnostic development
17-09-2014
OncoCyte Corporation, a subsidiary of BioTime, Inc. (NYSE MKT: BTX), and Abcodia Ltd., a UK-based company focusing on the early detection of... |
| 19.11.2013 | Abcodia's CEO Dr Julie Barnes wins 2013 WISE Award for Enterprise & Innovation | Abcodia's CEO Dr Julie Barnes wins 2013 WISE Award for Enterprise & Innovation
19-11-2013
The 2013 prestigious WISE award for Enterprise and Innovation has been awarded to Dr Julie Barnes, CEO of Abcodia. It was presented by HRH The Pri... |
| 18.09.2013 | Abcodia announces world-wide agreement for the ROCA ovarian cancer screening test | Abcodia today announced that it has entered into an agreement for an exclusive commercial licence for ROCA, which has the potential to be a major breakthrough for the early diagnosis of ovarian cancer.
Abcodia granted a world-wide exclusive... |
| 18.09.2013 | Abcodia announces world-wide agreement for the ROCA ovarian cancer screening test | Abcodia announces world-wide agreement for the ROCA ovarian cancer screening test
18-09-2013
Abcodia today announced that it has entered into an agreement for an exclusive commercial licence for ROCA, which has the potential to be a major b... |
| 12.06.2013 | Abcodia announces collaboration with the Austrian Institute of Technology | Abcodia announces collaboration with the Austrian Institute of Technology
12-06-2013
Abcodia, the biomarker validation company with a focus on cancer screening, today announced a collaboration with the AIT Austrian Institute of Technology w... |
| 06.06.2013 | Abcodia collaborates with Cancer Research UK and Cancer Research Technology | Abcodia collaborates with Cancer Research UK and Cancer Research Technology
06-06-2013
Abcodia today announces a collaboration with Cancer Research UK and Cancer Research Technology to develop new blood tests to detect a range of cancers wh... |
| 11.12.2012 | Abcodia scoops four top Startups Awards for pioneering work in cancer screening | Abcodia scoops four top Startups Awards for pioneering work in cancer screening
11-12-2012
Abcodia swept the board at the Startups Awards 2012 by scooping three top prizes, as well as being honoured as the overall NatWest Startups Business ... |
| 24.04.2012 | Abcodia and BIOUNIVERSA announce collaboration for early detection of pancreatic cancer | Abcodia and BIOUNIVERSA announce collaboration for early detection of pancreatic cancer
24-04-2012
Abcodia today announces its collaboration with BIOUNIVERSA for the development of a BAG3 biomarker for the early detection of pancreatic canc... |
| 17.02.2012 | Abcodia announces collaboration with VolitionRx to advance the discovery of blood based bi... | Abcodia, a biomarker validation company, has today announced a collaboration with life sciences company VolitionRx which will advance the development of biomarkers for the early detection of cancer.
The partnership will discover and develop... |
| 17.02.2012 | Abcodia announces collaboration with VolitionRx to advance the discovery of blood based bi... | Abcodia announces collaboration with VolitionRx to advance the discovery of blood based bi...
17-02-2012
Abcodia, a biomarker validation company, has today announced a collaboration with life sciences company VolitionRx which will advance t... |
| 15.06.2011 | Abcodia appoints Dr Wendy Alderton as Director of Science | Abcodia appoints Dr Wendy Alderton as Director of Science
15-06-2011
Abcodia makes a new key appointment of Dr Wendy Alderton as Director of Science following venture capital funding.
Abcodia, a company engaged in the validation and discove... |
| 25.05.2011 | Abcodia Raises £1M in Funding | Abcodia, a London, UK-based company engaged in the validation and discovery of molecular biomarkers for disease diagnosis and screening, has raised £1m in funding.
Investors include Albion Ventures and UCL Business Plc.
The company intends ... |
| 24.05.2011 | Abcodia secures £1 million funding | Abcodia secures £1 million funding
24-05-2011
Abcodia announces funding of £1 million to develop its visionary plans which could transform the way that life-threatening diseases are diagnosed.
Abcodia, a company engaged in the validation an... |
| 08.03.2011 | Collaborative partners sought for Abcodia, a newly launched molecular diagnostic company | Collaborative partners sought for Abcodia, a newly launched molecular diagnostic company
08-03-2011
Abcodia, a new company launched today by Cambridge biotech entrepreneurs, is seeking collaborative partners. It has been granted rights to c... |
